JMCB Symposium 2019:
The Legend of p53 vs. Cancer

JMCB Symposium 2019:
The Legend of p53 vs. Cancer

10−12 May 2019, Hangzhou, China


10−12 May 2019, Hangzhou, China

Register now Program

Speakers

Gareth L. Bond

Ludwig Institute for Cancer Research, Oxford University, UK

Jiandong Chen

Lee Moffitt Cancer Center, USA

Giannino Del Sal

University of Trieste, Italy

Xin-Hua Feng

Zhejiang University, China

Zhaohui Feng

Rutgers Cancer Institute of New Jersey, USA

Xin-Yuan Fu

West China Hospital, Sichuan University, China

David M. Gilbert

Florida State University, USA

Wei Gu

Columbia University, USA

Ygal Haupt

Peter MacCallum Cancer Centre, Australia

Wenwei Hu

Rutgers Cancer Institute of New Jersey, USA

Hai Jiang

SIBCB, CAS, China

Peng Jiang

Tsinghua University, China

Arnold J. Levine

Institute for Advanced Study, USA

Guohong Li

Institute of Biophysics, CAS, China

Guillermina Lozano

MD Anderson Cancer Institute, USA

Hua Lu

Tulane University, USA

Xin Lu

Ludwig Institute for Cancer Research, University of Oxford, UK

Min Lu

Shanghai Jiao Tong University School of Medicine, China

Jinrong Peng

Zhejiang University, China

Carol Prives

Columbia University, USA

Robert G. Roeder

Rockefeller University, USA

Kanaga Sabapathy

National Cancer Centre Singapore, Singapore

Weikang Tao

Jiangsu Hengrui Medicine Co., Ltd, China

Shaomeng Wang

University of Michigan, USA

Zhi-Xiong Xiao

Sichuan University

Guoliang Xu

SIBCB, CAS, China

Yang Xu

University of California, San Diego, USA

Dajun Yang

Ascentage Pharma (Suzhou) Co., Ltd

Zhi-Min Yuan

Harvard University School of Public Health, USA

Yi Zhang

Harvard University, USA

Yanping Zhang

University of North Carolina, USA

Ruiwen Zhang

University of Houston, USA

Bin-Bing Zhou

Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, China

Xiang Zhou

Shanghai Cancer Center and Institutes of Biomedical Sciences of Fudan University, China

Wei-Guo Zhu

Shenzhen University Health Science Center, China